Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Arbesda RespiClick (fluticasone propionate/salmeterol xinafoate)
pCPA File Number:
21073
Negotiation Status:
Concluded without agreement
Indication(s):
Asthma
Sponsor/Manufacturer:
Teva Canada Limited
CADTH Project Number:
SR0540-000
pCPA Engagement Letter Issued:
2019-04-12
Negotiation Process Concluded:
2019-07-31